Yasha Modi, MD; Kyle Kovacs, MD; Priya Vakharia, MD
Show Description +
Two biosimilars have been approved for retinal indications. What conclusions were drawn from the phase 3 studies that preceded their approval? Yasha Modi, MD, is joined by Kyle Kovacs, MD, and Priya Vakharia, MD, to review the ins and outs of biosimilarity, discuss the findings of two recent papers, and consider how use of biosimilars might affect future clinical practice in the United States.
Posted: 11/17/2022
Yasha Modi, MD; Kyle Kovacs, MD; Priya Vakharia, MD
Two biosimilars have been approved for retinal indications. What conclusions were drawn from the phase 3 studies that preceded their approval? Yasha Modi, MD, is joined by Kyle Kovacs, MD, and Priya Vakharia, MD, to review the ins and outs of biosimilarity, discuss the findings of two recent papers, and consider how use of biosimilars might affect future clinical practice in the United States.
Posted: 11/17/2022
New Retina Radio is forging forward with education, and they’re partnering with Vit Buckle Society to make it happen. Check out these quick-hit reviews of journal articles delivered by VBS members.
New Retina Radio Journal Club: Biosimilars in Retina: A Pair of Phase 3 Papers
Yasha Modi, MD; Kyle Kovacs, MD; Priya Vakharia, MD
Please log in to leave a comment.